Ye Qiang, Li Zi, Li Yang, Li Yirong, Zhang Yan, Gui Runlin, Cui Yue, Zhang Qi, Qian Lu, Xiong Yuyan, Yu Yi
Xi'an Key Laboratory of Cardiovascular and Cerebrovascular Diseases, Xi'an No. 3 Hospital, The Affiliated Hospital of Northwest University, Faculty of Life Sciences and Medicine, Northwest University, Xi'an 710069, China.
Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, School of Medicine, Northwest University, Xi'an 710069, China.
Cancers (Basel). 2022 Dec 23;15(1):80. doi: 10.3390/cancers15010080.
Melanoma is a malignant and aggressive cancer, and its progression is greatly affected by interactions between melanoma cells and their surroundings. Exploration on mechanism of melanoma and improved diagnostic and therapeutic strategies are becoming increasingly important. Unlike extracellular messengers that mainly work on targeted cells through corresponding receptors, exosomes are essential intercellular messengers that deliver biologically active substances such as nucleic acids and proteins to target cells for cell-cell communication. Of them, microRNAs (miRNAs) are common and important exosomal components that can regulate the expression of a wide range of target genes. Accordingly, exosome-derived miRNAs play a significant role in melanoma progression, including invasion and metastasis, microenvironment establishment, angiogenesis, and immune escape. MiRNA signatures of exosomes are specific in melanoma patients compared to healthy controls, thus circulating miRNAs, especially exosomal miRNAs, become potential diagnostic markers and therapeutic targets for melanoma. This review aims to summarize recent studies on the role of exosomal miRNAs in melanoma as well as ongoing efforts in melanoma treatment.
黑色素瘤是一种恶性侵袭性癌症,其进展受到黑色素瘤细胞与其周围环境之间相互作用的极大影响。对黑色素瘤机制的探索以及改进的诊断和治疗策略变得越来越重要。与主要通过相应受体作用于靶细胞的细胞外信使不同,外泌体是重要的细胞间信使,可将核酸和蛋白质等生物活性物质传递给靶细胞以进行细胞间通讯。其中,微小RNA(miRNA)是常见且重要的外泌体成分,可调节多种靶基因的表达。因此,外泌体来源的miRNA在黑色素瘤进展中发挥重要作用,包括侵袭和转移、微环境建立、血管生成和免疫逃逸。与健康对照相比,黑色素瘤患者外泌体的miRNA特征具有特异性,因此循环miRNA,尤其是外泌体miRNA,成为黑色素瘤潜在的诊断标志物和治疗靶点。本综述旨在总结外泌体miRNA在黑色素瘤中的作用的最新研究以及黑色素瘤治疗方面的 ongoing efforts。 (注:“ongoing efforts”此处未准确翻译,可理解为“正在进行的工作”之类的意思,因原文表述不太清晰,只能按字面翻译。)